Literature DB >> 8864562

Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine.

R G Pertwee1, S R Fernando, J E Nash, A A Coutts.   

Abstract

1. CP 50,556, CP 55,940, nabilone, CP 56,667, delta 9 -tetrahydrocannabinol (THC) and cannabinol each inhibited electrically-evoked contractions of the myenteric plexus-longitudinal muscle preparation of guinea-pig small intestine in a concentration-related manner. The IC50 values of these cannabinoids, respectively 3.45, 3.46, 30.61, 162.94, 214.63, and 3913.5 nM, correlate well with previously obtained potency values for displacement of [3H]-CP 55,940 from cannabinoid binding sites. 2. Electrically-evoked contractions of the myenteric plexus-longitudinal muscle preparation were also inhibited by AM 630 (6-iodo-pravadoline) and by WIN 55,212-2 (IC50 = 1923.0 and 5.54 nM, respectively). The present finding that AM 630 is an agonist, contrasts with a previous observation that it behaves as a cannabinoid receptor antagonist in the mouse isolated vas deferens. 3. SR141716A produced dose-related parallel rightward shifts in the log concentration-response curves of CP 55,940, WIN 55,212-2, THC and AM 630 for inhibition of electrically-evoked contractions of the myenteric plexus-longitudinal muscle preparation. SR141716A (1 microM) did not reverse the inhibitory effects of normorphine and clonidine on electrically-evoked contractions or potentiate the contractile response to acetylcholine. 4. Doses of naloxone and yohimbine that reversed the inhibitory effects of normorphine or clonidine on electrically-evoked contractions of the myenteric plexus-longitudinal muscle preparation did not affect the inhibitory response to WIN 55,212-2. 5. Electrically-evoked release of acetylcholine from strips of myenteric plexus-longitudinal muscle was decreased by 200 nM CP 55,940 and this inhibitory effect was almost completely reversed by 1 microM SR141716A. Acetylcholine-induced contractions were not affected by 200 nM CP 55,940. 6. These results support the hypothesis that guinea-pig small intestine contains prejunctional cannabinoid CB1 receptors through which cannabinoids act to inhibit electrically-evoked contractions by reducing release of the contractile transmitter, acetylcholine. 7. THC was found to be more susceptible to antagonism by SR141716A than CP 55,940 or AM 630, raising the possibility that guinea-pig small intestine contains more than one type of cannabinoid receptor. 8. At concentrations of 10 nM and above, SR141716A produced small but significant increases in the amplitude of electrically-evoked contractions of the myenteric plexus-longitudinal muscle preparation suggesting that this tissue may release an endogenous cannabinoid receptor agonist or that some cannabinoid receptors in this tissue are precoupled and that SR141716A can reduce the number of receptors in this state.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864562      PMCID: PMC1909886          DOI: 10.1111/j.1476-5381.1996.tb15663.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  The two-state model of receptor activation.

Authors:  P Leff
Journal:  Trends Pharmacol Sci       Date:  1995-03       Impact factor: 14.819

Review 2.  pA2 and receptor differentiation: a statistical analysis of competitive antagonism.

Authors:  R J Tallarida; A Cowan; M W Adler
Journal:  Life Sci       Date:  1979-08-20       Impact factor: 5.037

3.  Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens.

Authors:  R G Pertwee; G Griffin; J A Lainton; J W Huffman
Journal:  Eur J Pharmacol       Date:  1995-09-25       Impact factor: 4.432

4.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

5.  Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine.

Authors:  R G Pertwee; L A Stevenson; D B Elrick; R Mechoulam; A D Corbett
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

6.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

Authors:  R Mechoulam; S Ben-Shabat; L Hanus; M Ligumsky; N E Kaminski; A R Schatz; A Gopher; S Almog; B R Martin; D R Compton
Journal:  Biochem Pharmacol       Date:  1995-06-29       Impact factor: 5.858

7.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

8.  The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips.

Authors:  W D Paton; M A Zar
Journal:  J Physiol       Date:  1968-01       Impact factor: 5.182

9.  AM630, a competitive cannabinoid receptor antagonist.

Authors:  R Pertwee; G Griffin; S Fernando; X Li; A Hill; A Makriyannis
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

10.  In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.

Authors:  L J Sim; D E Selley; S R Childers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  33 in total

1.  Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens.

Authors:  A Christopoulos; P Coles; L Lay; M J Lew; J A Angus
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

2.  Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.

Authors:  R A Ross; H C Brockie; L A Stevenson; V L Murphy; F Templeton; A Makriyannis; R G Pertwee
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 3.  Cannabinoids and the gastrointestinal tract.

Authors:  R G Pertwee
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

4.  Modulation of the release of endogenous adenosine by cannabinoids in the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum.

Authors:  M Begg; N Dale; E Llaudet; A Molleman; M E Parsons
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 5.  Involvement of cannabinoid receptors in gut motility and visceral perception.

Authors:  Pamela J Hornby; Stephen M Prouty
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

6.  Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips.

Authors:  Fabio Guagnini; Paola Cogliati; Sylvain Mukenge; Gianfranco Ferla; Tiziano Croci
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

7.  Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice.

Authors:  Mauro A M Carai; Giancarlo Colombo; Gian Luigi Gessa; Ratnakumar Yalamanchili; Balapal S Basavarajappa; Balapal S Basavarajppa; Basalingappa L Hungund
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

8.  Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats.

Authors:  Ronald Mathison; Winnie Ho; Quentin J Pittman; Joseph S Davison; Keith A Sharkey
Journal:  Br J Pharmacol       Date:  2004-07-12       Impact factor: 8.739

Review 9.  Intestinal lipid-derived signals that sense dietary fat.

Authors:  Nicholas V DiPatrizio; Daniele Piomelli
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

10.  Molecules Acting on CB1 Receptor and their Effects on Morphine Withdrawal In Vitro.

Authors:  Anna Capasso; Chiara Gallo
Journal:  Open Biochem J       Date:  2009-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.